ADL has no equal in trial acceleration; our approach uses a data-driven approach to effectively deliver results very quickly
Accelerate RX
CLINICAL TRIAL ACCELERATION
Successful and on-time pivotal clinical trials are crucial for delivering new and improved treatments for patients with serious illnesses and unlocking lucrative market opportunities for the trial sponsors. However, delays in completing these trials are exceedingly common
We unlock strategies and tactics that shorten the time it takes to bring new drugs and therapies to patients. With clinical trial acceleration, we offer external insights, new ways of thinking, and make the connections needed in:
Results and outcome
We enabled a leading Biotech company to take over a year off their pivotal trial’s time to completion and submission
- A clinical trial for a chronic, complex autoimmune disorder
- The disease affects a hundred per million; finding patients was very challenging
- The trial was trending towards a 14-month delay with $mm in operational costs
- Evaluate projected $1.2 billion in sales in four years if the product was launched ahead of the competition
- With ADL support, the trial was brought in 16 months earlier than the projected trend, two months ahead of the corporate baseline target
- Patient-centric focus
- AI in site identification
- Rapid and continuous feedback (esp. COVID-19)
- Competitive modelling
- Data-driven projections
- One-source of truth dash
- Multi-vendor incentives
Top level approach
Our approach is proprietary and marries deep therapy area knowledge, data and analytics with solution execution to accelerate clinical trials
01 DISCOVER the key levers..
Discover the current gaps, trial trajectory and “what it takes to win”
02 MOBILIZE the organization..
Inspire the trial team and align on all points to drive the desired outcome
03 ACCELERATE smartly
Implement with excellence while constantly measuring the effectiveness of the accelerators
Our approach is effective and delivers immediate impact
Our end-to-end framework is used to ensure diligence in opportunity assessment at a very granular level of detail
Track Record
We bring extensive experience of accelerating clinical trials for different sponsors across multiple therapy areas
EXTENSIVE BREADTH OF CLINICAL TRIAL ACCELERATION EXPERIENCE
ACCELERATING CURES
The key stakeholders in the healthcare system, i.e. patients, providers, payers, and drug developers, all benefit from a win in on-time clinical trial execution. Patients receive quicker access to new treatments, providers and payers gain innovative ways to meet their patients’ needs, and drug developers achieve a successful ROI for the risk taken by investors.
GET IN
TOUCH
BEN ENEJO
PARTNER, BOSTON
BEN VAN DER SCHAAF
PARTNER, NEW YORK
CRAIG WYLIE
PARTNER, BOSTON
SHREYA MODI
MANAGER, NEW YORK
EMMANUEL AISABOKHAE
PRINCIPAL, NEW YORK
